Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (40)

2024

  1. Prognostic and survival factors in head and neck extra-nodal non-Hodgkin's lymphoma

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

2023

  1. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

    Frontiers in Oncology, Vol. 13

2022

  1. Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

    HemaSphere, Vol. 6, Núm. 4

2021

  1. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes

    PloS one, Vol. 16, Núm. 5, pp. e0248886

  2. Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

    PloS one, Vol. 16, Núm. 2, pp. e0247093

  3. Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

    Frontiers in Oncology, Vol. 11

  4. Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models

    Frontiers in Oncology, Vol. 11

  5. Safety of FLT3 inhibitors in patients with acute myeloid leukemia

    Expert Review of Hematology, Vol. 14, Núm. 9, pp. 851-865

  6. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

    Leukemia, Vol. 35, Núm. 10, pp. 2924-2935

  7. The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia

    Expert Opinion on Drug Safety, Vol. 20, Núm. 7, pp. 791-799

  8. Variable expressivity and allelic heterogeneity in type 2 familial partial lipodystrophy: The p.(thr528met) lmna variant

    Journal of Clinical Medicine, Vol. 10, Núm. 7

2020

  1. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study

    Blood, Vol. 135, Núm. 5, pp. 381-386

  2. FLT3 inhibitors in the treatment of acute myeloid leukemia: Current status and future perspectives

    Minerva Medica, Vol. 111, Núm. 5, pp. 427-442

  3. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

    BMC Cancer, Vol. 20, Núm. 1

  4. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome

    Scientific Reports, Vol. 10, Núm. 1

  5. Proteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion

    Journal of Proteomics, Vol. 210

  6. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

    Annals of Hematology, Vol. 99, Núm. 4, pp. 799-808

  7. Use of Magnetic Resonance Imaging in the Evaluation of Mediastinal and Systemic Disease in Lymphoma. A Systematic Review

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 151-157

2019

  1. A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia

    Journal of Oncology, Vol. 2019

  2. Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia

    Blood cancer journal